Clinical correlation of mesenteric vascular disease in older patients

Fabrizio Cardin1, Stefania Fratta, Egle Perissinotto

  • 1Department of Surgical and Gastroenterological Sciences, University of Padova Hospital, Padova, Italy. fabrizio.cardin@sanita.padova.it

Insights

Chronic mesenteric ischemia (CMI) diagnosis in older adults differs from the general population. Key indicators include lower BMI, longer hospital stays, and diarrhea, differentiating geriatric CMI patients.

Area of Science:

  • Vascular Surgery
  • Geriatric Medicine
  • Diagnostic Imaging

Background:

  • Mesenteric vascular obstruction presents varied clinical pictures, complicating diagnosis.
  • Traditional Chronic Mesenteric Ischemia (CMI) diagnosis predates advanced imaging and considers fewer comorbidities common in aging populations.

Purpose of the Study:

  • To investigate clinical characteristics of CMI in patients over 65.
  • To identify differences in CMI presentation between geriatric and general populations.

Main Methods:

  • Retrospective analysis of 85 patients over 65 undergoing angio-CT scans.
  • Comparison of patients with mesenteric vessel occlusion (n=34) to controls.
  • Stepwise logistic analysis to identify predictive factors for CMI in the elderly.

Main Results:

  • Patients with mesenteric artery disease showed lower BMI (24.9 vs 26.8) and longer hospital stays (14 vs 6 days).
  • Higher prevalence of vasculopathies (97.1% vs 80.4%) and diarrhea (21.2% vs 5.9%) were noted in the CMI group.
  • A predictive model including hospital stay, vasculopathies, diarrhea, and benzodiazepine use achieved an AUC of 0.81.

Conclusions:

  • Geriatric CMI patients exhibit distinct features compared to younger cohorts.
  • Lower BMI, prolonged hospitalization, and diarrhea are significant indicators in elderly CMI patients.
  • Diagnostic criteria for CMI require adaptation for the aging demographic.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...